Participated · Series B · Jun 2026

Zumutor Biologics is a biotech company working on cancer therapies and currently advancing clinical trials for its programs. The company announced it raised $7.3 million, which the report states will be used to progress those clinical studies. The article does not include details on commercial products, revenues, users, or other operating metrics. It also does not provide information on the company's founding year, location, or past financing rounds. The available coverage is focused on the new capital and its intended application toward clinical development.

Led · Series A · Jun 2024

Clodura.AI builds an AI-driven sales prospecting platform that leverages large language models (LLMs) and generative AI to accelerate the sales process from prospecting to closing. The platform automates outreach campaigns, helps identify decision-makers, and collects actionable sales intelligence to create a 10X sales pipeline. It includes email cadence features that automate follow-ups and scheduling to reduce manual labor and increase meetings. The company plans to use the new funding to improve the Clodura.AI platform and its AI capabilities. Clodura.AI raised $2 million in a pre-Series A round led by Bharat Innovation Fund with support from Malpani Ventures. Founder Kapil Khangaonkar is named in the announcement.

Led · Equity · May 2024

Portl is an Indian digital fitness firm that offers a connected smart mirror to enable at-home workouts. The article describes the smart mirror as the company’s core product. Portl announced it raised $3 million in a funding round led by Bharat Innovation Fund (BIF). No revenue, user metrics, or broader financial details were provided in the article. The report did not disclose future plans, product roadmap, or additional operational details. The coverage is limited to the fundraising announcement and product description. Portl builds integrated, multi-functional smart fitness and health systems centered on a proprietary Portl Smart Mirror platform. The company has developed two products — the Portl Mirror (a 43" 4K intelligent mirror with embedded bio-sensors, HD cameras, edge-AI processing, and telemedicine integrations) and the Portl Pro (a 32" mirror with a proprietary digital weight mechanism delivering over 100Kg of electronic resistance). Both devices use advanced AI for real-time exercise form analysis and correction and include bio-sensors that monitor metrics such as ECG, blood pressure, and blood glucose to enable personalized wellness programs. Founded in March 2021 and based in Hyderabad, Portl plans to use the newly raised funds to grow its hardware, engineering and AI teams and to expand sales and marketing for its product range in India. The company expects its products to be available for consumers later this year. Portl raised seed funding from Kalaari Capital, though the amount of the deal was not disclosed.

Led · Series A · Apr 2024

ClaimBuddy is a health insurance claim assistance platform that simplifies the claims process by enabling cashless, hassle-free experiences for patients and hospitals. Founded in 2020 and based in Gurugram, the company says it has processed claims for over 35,000 patients valued at more than Rs 500 crore and has collaborations with 250+ partner hospitals across India. The startup addresses delays in discharge and reimbursement under the reimbursement mode and acts as a healthcare-financing and claim facilitation tool. It plans to use new funding to advance its technology, expand its team and sales network, and add new product lines for its growing hospital network. Management also intends to introduce innovative financial tools and scale operations to improve patient access to quality care. The company is backed by investors including Chiratae Ventures and Rebright Partners. ClaimBuddy is a healthtech startup that provides digital infrastructure to hospitals for patient health insurance claims. It acts as a one-stop solution for insurance claims processing by leveraging technology and strong operations, and offers tech and financing solutions to hospitals and doctors. The company says its offerings improve operational and financial efficiency by at least 30% while improving patient experience. ClaimBuddy has processed claims of more than 100 crores and is working with 120+ hospitals. Founded by IIM‑Bangalore alumni, the startup has witnessed 10x growth over the past year. It plans to use the $3M to strengthen its technology framework and increase sales and marketing efforts. ClaimBuddy, operated by Claimbuddy Technologies Pvt Ltd, provides a platform where medical claim specialists evaluate insurance to resolve queries and provide coverage assistance. The service targets pain points in the claims process for hospitals and patients, aiming to reduce delays, deductions, and rejections. The startup says it has processed claims worth over Rs 15 crore across more than 50 partner hospitals in Delhi‑NCR, Bengaluru, and Mumbai. ClaimBuddy highlights that over 90% of Indian hospitals are individually owned and often lack the technology and domain expertise to manage insurance efficiently. The company will use the capital from its seed round to expand across India and to enhance its technological infrastructure. It was set up by founders Khet Singh and Ajit Patel.

Led · Series A · Feb 2024

AlgoBio’s core product is a platform technology that functions as a molecular-testing equivalent of a compression algorithm, using AI and sophisticated algorithms to boost throughput and efficiency. The company has applied its platform across healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research. AlgoBio launched a fast Covid testing solution that is patented and is expanding its offering to include additional diagnostic tests. Its product Tapestry enables affordable campus-wide Covid-19 screening. The company recently partnered with Dhiti Omics Technologies, an Indian molecular diagnostic services provider. AlgoBio plans to use new funding to develop its sales force, support its product pipeline, and broaden its geographic reach.